to find high-affinity antibodies against their desired target. Alternatively, companies may wish to partner with Twist Biopharma to build a custom library in a vector and scaffold of their choice.
For the last 30 years, the production of affinity reagents and particularly antibodies for research and therapeutic applications has been dominated by hybridoma and polyclonal technologies ...
Humanization of mouse monoclonal antibodies or alpaca nanobody by genetic engineering can increase their similarity to antibodies naturally produced in humans, greatly enhancing their in vivo ...